9E

Evolent Health IncFRA Evolent Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

3.438

Middle

Exchange

XFRA - Deutsche Boerse AG

9EH.F Stock Analysis

9E

Uncovered

Evolent Health Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-10/100

Low score

Market cap $B

3.438

Dividend yield

Shares outstanding

111.05 B

Evolent Health, Inc. engages in the provision of health care delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 5,100 full-time employees. The company went IPO on 2015-06-05. The firm supports health systems and physician organizations as well as health plans to move their business models from traditional fee-for-service reimbursement to value-based care. The firm operates through two segments: Clinical Solutions and Evolent Health Services. The Clinical Solutions segment includes its specialty management and physician-oriented total cost of care solutions, along with the New Century Health, Vital Decisions, IPG, NIA, and Evolent Care Partners brands. Its Clinical Solutions segment offers two solutions, namely specialty care management services and total cost of care management. Its care management services include population health performance and delivery network alignment. The Evolent Health Services segment includes integrated value-based care platform designed to help its customers manage and administer patient health.

View Section: Eyestock Rating